Access the full text.
Sign up today, get DeepDyve free for 14 days.
Xiao Wang, Lingdi Wang, Lu Zhu, Yi Pan, Fei Xiao, Weizhong Liu, Zhenzhen Wang, F. Guo, Yong Liu, Walter Thomas, Yan Chen (2013)
PAQR3 Modulates Insulin Signaling by Shunting Phosphoinositide 3-Kinase p110α to the Golgi ApparatusDiabetes, 62
Baselga (2012)
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancerN. Engl. J. Med, 366
Hong-ge Wu, W. Zhang, Q. Ding, G. Peng, Zhen-wei Zou, Ting Liu, Ru-bo Cao, S. Fei, Peng-Cheng Li, Kun-yu Yang, Jian-Li Hu, Xiang Dai, Gang Wu, Pin-dong Li (2014)
Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.Oncology reports, 32 6
J. Thigpen (2012)
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast CancerYearbook of Oncology, 2012
H. Matsushime, M. Ewen, D. Strom, J. Kato, S. Hanks, M. Roussel, C. Sherr (1992)
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclinsCell, 71
J. Klijn, L. Beex, L. Mauriac, Jacobus Zijl, C. Veyret, J. Wildiers, J. Jassem, M. Piccart, J. Burghouts, D. Becquart, Carolien Seynaeve, F. Mignolet, L. Duchateau (2000)
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.Journal of the National Cancer Institute, 92 11
A. Leo, G. Jerusalem, L. Petruželka, R. Torres, I. Bondarenko, R. Khasanov, D. Verhoeven, J. Pedrini, I. Smirnova, M. Lichinitser, K. Pendergrass, Sally Garnett, J. Lindemann, F. Sapunar, Miguel Martín (2010)
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 30
Yuhui Jiang, Xiaoduo Xie, Zhigang Li, Zheng-Wu Wang, Yixuan Zhang, Z. Ling, Yi Pan, Zhenzhen Wang, Yan Chen (2011)
Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition.Cancer research, 71 8
C. Thangavel, Jeffry Dean, A. Ertel, K. Knudsen, Claudio Aldaz, A. Witkiewicz, R. Clarke, E. Knudsen (2011)
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.Endocrine-related cancer, 18 3
Qiang Wu, Kun Zhuang, Huijun Li (2015)
PAQR3 plays a suppressive role in laryngeal squamous cell carcinomaTumor Biology, 37
Yuhui Jiang, Xiaoduo Xie, Yixuan Zhang, Xiaolin Luo, Xiao Wang, Fengjuan Fan, Dawei Zheng, Zhenzhen Wang, Yan Chen (2009)
Regulation of G-Protein Signaling by RKTG via Sequestration of the Gβγ Subunit to the Golgi ApparatusMolecular and Cellular Biology, 30
Y. Zhang, Xiaomeng Jiang, X. Qin, D. Ye, Zhengfang Yi, Mingyao Liu, O. Bai, W. Liu, Xiaoduo Xie, ZhenZhen(王甄真) Wang, J. Fang, Yan(陈雁) Chen (2010)
RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinomaOncogene, 29
U. Asghar, A. Witkiewicz, N. Turner, E. Knudsen (2015)
The history and future of targeting cyclin-dependent kinases in cancer therapyNature Reviews Drug Discovery, 14
Z. Ling, Weiwei Guo, X. Lu, X. Zhu, L. Hong, ZhenZhen(王甄真) Wang, Yan(陈雁) Chen (2014)
A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers.Annals of oncology : official journal of the European Society for Medical Oncology, 25 7
A. Leo, G. Jerusalem, L. Petruželka, R. Torres, I. Bondarenko, R. Khasanov, D. Verhoeven, J. Pedrini, I. Smirnova, M. Lichinitser, K. Pendergrass, L. Malorni, Sally Garnett, Y. Rukazenkov, Miguel Martín (2013)
Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM TrialJNCI Journal of the National Cancer Institute, 106
Zhenghu Li, Z. Ling, W. Guo, Xiao-xiao Lu, Yi Pan, Zhenzhen Wang, Yan Chen (2015)
PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expressionOncotarget, 6
E. Musgrove, C. Caldon, Jane Barraclough, Andrew Stone, R. Sutherland, R. Sutherland (2011)
Cyclin D as a therapeutic target in cancerNature Reviews Cancer, 11
Lin Feng, Xiaoduo Xie, Q. Ding, Xiaolin Luo, Jing He, Fengjuan Fan, Weizhong Liu, Zhenzhen Wang, Yan Chen (2007)
Spatial regulation of Raf kinase signaling by RKTGProceedings of the National Academy of Sciences, 104
T. Mosmann (1983)
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.Journal of immunological methods, 65 1-2
R. Siegel, K. Miller, A. Jemal (2015)
Cancer statistics, 2015CA: A Cancer Journal for Clinicians, 65
Zhiqiang Ma, Yanlong Wang, Taikui Piao, Zhao-peng Li, Hongyu Zhang, Zhixin Liu, Jianyu Liu (2015)
The tumor suppressor role of PAQR3 in osteosarcomaTumor Biology, 36
N. Turner, C. Bartlett, M. Cristofanilli (2015)
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.The New England journal of medicine, 373 17
Qunyan Yu, E. Sicinska, Y. Geng, Marie Ahnström, A. Zagozdzon, Y. Kong, H. Gardner, H. Kiyokawa, L. Harris, O. Stål, P. Sicinski (2006)
Requirement for CDK4 kinase function in breast cancer.Cancer cell, 9 1
Y. Tang, T. Hu, M. Arterburn, B. Boyle, J. Bright, P. Emtage, W. Funk (2005)
PAQR Proteins: A Novel Membrane Receptor Family Defined by an Ancient7-Transmembrane Pass MotifJournal of Molecular Evolution, 61
Turner (2015)
Palbociclib in hormone-receptor-positive advanced breast cancerN. Engl. J. Med, 373
S. Rane, P. Dubus, R. Mettus, E. Galbreath, G. Boden, E. Reddy, M. Barbacid (1999)
Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasiaNature Genetics, 22
Xiao Wang, Lingdi Wang, Lu Zhu, Yi Pan, Fei Xiao, Weizhong Liu, Zhenzhen Wang, F. Guo, Yong Liu, Walter Thomas, Yan Chen (2012)
PAQR 3 Modulates Insulin Signaling by Shunting Phosphoinositide 3-Kinase p 110 a to the Golgi Apparatus
O. Abe, R. Abe, K. Enomoto, K. Kikuchi, H. Koyama, H. Masuda, Y. Nomura, K. Sakai, K. Sugimachi, T. Tominaga, J. Uchino, M. Yoshida, J. Haybittle, C. Davies, V. Harvey, TM Holdaway, R. Kay, B. Mason, J. Forbes, N. Wilcken, M. Gnant, R. Jakesz, M. Ploner, H. Yosef, C. Focan, J. Lobelle, U. Peek, G. Oates, J. Powell, M. Durand, L. Mauriac, A. Leo, S. Dolci, M. Piccart, M. Masood, D. Parker, J. Price, P. Hupperets, S. Jackson, J. Ragaz, D. Berry, G. Broadwater, C. Cirrincione, H. Muss, L. Norton, R. Weiss, H. Abu‐Zahra, S. Portnoj, M. Baum, J. Cuzick, J. Houghton, D. Riley, NH Gordon, H. Davis, A. Beatrice, J. Mihura, A. Naja, Y. Lehingue, P. Romestaing, JB Dubois, T. Delozier, J. Macé-Lesec’h, P. Rambert, O. Andrysek, J. Barkmanova, Owen, P. Meier, A. Howell, G. Ribeiro, R. Swindell, R. Alison, J. Boreham, M. Clarke, R. Collins, S. Darby, P. Elphinstone, Evans, J. Godwin, R. Gray, C. Harwood, C. Hicks, S. James, E. Mackinnon, P. Mcgale, T. McHugh, G. Mead, R. Peto, Y. Wang, J. Albano, Cf Oliveira, H. Gervásio, J. Gordilho, H. Johansen, H. Mouridsen, R. Gelman, Harris, I. Henderson, Claire Shapiro, K. Andersen, C. Axelsson, M. Blichert‐Toft, S. Møller, J. Overgaard, M. Overgaard, C. Rose, B. Cartensen, T. Palshof, H. Trampisch, O. Dalesio, D. Vries, S. Rodenhuis, H. Tinteren, R. Comis, N. Davidson, N. Robert, G. Sledge, D. Tormey, W. Wood, D. Cameron, U. Chetty, P. Forrest, W. Jack, J. Rossbach, J. Klijn, A. Treurniet‐Donker, W. Putten, Alberto Costa, U. Veronesi, H. Bartelink, L. Duchateau, C. Legrand, R. Sylvester, J. Hage, C. Velde, M. Cunningham, R. Catalano, R. Creech, J. Bonneterre, P. Fargeot, P. Fumoleau, P. Kerbrat, M. Namer, W. Jonat, M. Kaufmann, M. Schumacher, G. Minckwitz, G. Bastert, H. Rauschecker, R. Sauer, W. Sauerbrei, A. Schauer, A. Schryver, L. Vakaet, M. Belfiglio, A. Nicolucci, F. Pellegrini, M. Sacco, M. Valentini, C. McArdle, D. Smith, E. Galligioni, F. Boccardo, A. Rubagotti, D. Dent, C. Gudgeon, A. Hacking, A. Erazo, J. Medina, M. Izuo, Y. Morishita, H. Takei, I. Fentiman, J. Hayward, R. Rubens, D. Skilton, H. Graeff, F. Jänicke, C. Meisner, H. Scheurlen, D. Fournier, U. Dafni, G. Fountzilas, P. Klefstrom, C. Blomqvist, T. Saarto, R. Margreiter, B. Asselain, R. Salmon, Vilcoq, R. Arriagada, C. Hill, A. Laplanche, M. Lê, M. Spielmann, P. Bruzzi, E. Montanaro, R. Rosso, Sertoli, M. Venturini, D. Amadori, J. Benraadt, M. Kooi, A. Velde, J. Dongen, J. Vermorken, M. Castiglione, F. Cavalli, A. Coates, J. Collins, J. Forbes, R. Gelber, A. Goldhirsch, J. Lindtner, K. Price, C. Rudenstam, H. Senn, J. Bliss, C. Chilvers, R. Coombes, E. Hall, M. Marty, R. Borovik, G. Brufman, H. Hayat, E. Robinson, N. Wigler, G. Bonadonna, T. Camerini, G. Palo, M. Vecchio, F. Formelli, P. Valagussa, A. Martoni, F. Pannuti, G. Cocconi, A. Colozza, R. Camisa, K. Aogi, S. Takashima, T. Ikeda, K. Inokuchi, K. Sawa, H. Sonoo, S. Korzeniowski, J. Skołyszewski, M. Ogawa, J. Yamashita, J. Bonté, R. Christiaens, R. Paridaens, W. Boegart, P. Martin, S. Romain, T. Hakes, C. Hudis, R. Wittes, G. Giokas, D. Kondylis, B. Lissaios, R. Huerta, MG Sainz, R. Altemus, K. Cowan, D. Danforth, A. Lichter, M. Lippman, J. O’Shaughnessy, L. Pierce, S. Steinberg, D. Venzon, J. Zujewski, A. Paradiso, M. Lena, F. Schittulli, J. Myles, J. Pater, K. Pritchard, S. Anderson, G. Bass, Andrew Brown, J. Bryant, J. Costantino, J. Dignam, B. Fisher, C. Redmond, S. Wieand, N. Wolmark, I. Jackson, M. Palmer, J. Ingle, V. Suman, N. Bengtsson, H. Jonsson, L. Larsson, J. Lythgoe, M. Kissin, B. Erikstein, E. Hannisdal, Abby Jacobsen, J. Varhaug, S. Gundersen, M. Hauer-Jensen, H. Høst, R. Nissen-Meyer, R. Blamey, A. Mitchell, D. Morgan, J. Robertson, M. Palma, G. Mathé, J. Misset, R. Clark, M. Levine, K. Morimoto, Y. Takatsuka, E. Crossley, A. Harris, D. Talbot, Marianne Taylor, B. Blasio, Ivanov, Semiglazov, J. Brockschmidt, Cooper, H. Ueo, C. Falkson, R. a'Hern, S. Ashley, T. Powles, I. Smith, Yarnold, Gazet Jc, N. Cocoran, N. Deshpande, L. Martino, P. Douglas, A. Lindtner, G. Notter, Ajs Bryant, G. Ewing, L. Firth, J. Krushen-Kosloski, L. Foster, W. George, H. Stewart, P. Stroner, P. Malmström, T. Möller, S. Rydén, Tengrup, L. Tennvall-Nittby, J. Carstenssen, M. Dufmats, T. Hatschek, B. Nordenskjöld, M. Söderberg, J. Carpenter, K. Albain, James Crowley, S. Green, S. Martino, C. Osborne, P. Ravdin, U. Glas, U. Johansson, L. Rutqvist, T. Singnomklao, A. Wallgren, R. Maibach, B. Thürlimann, H. Brenner, A. Hercbergs, M. Yoshimoto, G. Deboer, A. Paterson, J. Meakin, T. Panzarella, Y. Shan, Y. Shao, Y Wang, DB Zhao, Zm Chen, HC Pan, J. Bahi, M. Reid, M. Spittle, Gp Deutsch, F. Senanayake, D. Kwong, A. Bianco, C. Carlomagno, M. Laurentiis, S. Placido, A. Buzdar, Thomas Smith, J. Bergh, L. Holmberg, G. Liljegren, J. Nilsson, M. Seifert, P. Sevelda, C. Zielinsky, R. Buchanan, M. Cross, G. Royle, J. Dunn, R. Hills, M. Lee, J. Morrison, D. Spooner, A. Litton, R. Chlebowski, H. Caffier, Ebctcg (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 365
Jing‐jing Zhao, K. Pan, Jian‐jun Li, Yi-bing Chen, Ju-gao Chen, Lin Lv, Dan-dan Wang, Q. Pan, Minshan Chen, J. Xia (2011)
Identification of LZAP as a New Candidate Tumor Suppressor in Hepatocellular CarcinomaPLoS ONE, 6
Xiao Wang, Xuebing Li, Fengjuan Fan, S. Jiao, Lingdi Wang, Lu Zhu, Yi Pan, Guohao Wu, Z. Ling, Jing Fang, Yan Chen (2012)
PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers.Carcinogenesis, 33 11
Progestin and adipoQ receptor 4 (PAQR4) is a member of the PAQR family, and the members within this family are involved in the regulation of a number of biological processes including metabolism and cancer development. The potential function of PAQR4 in human cancers is unknown. Analysis of ONCOMINE database reveals that PAQR4 is highly expressed in human breast cancers. We confirmed this finding by analyzing 82 human breast cancers samples. PAQR4 mRNA level was significantly upregulated in human breast cancer samples compared with their corresponding para-cancerous histological normal tissues (P < 0.0001). The mRNA level of PAQR4 was negatively correlated with disease-free survival (P < 0.0001) and overall survival of the patients (P = 0.001). Knockdown of PAQR4 in human breast cancer cells SUM159 and MCF7 suppressed cell proliferation. In contrast, overexpression of PAQR4 in SUM159 cells enhanced cell proliferation and colony formation. In a tumor xenograft model, overexpression of PAQR4 promoted tumor growth of SUM159 cells in vivo, while PAQR4 knockdown suppressed the tumor growth. PAQR4 was able to negatively regulate cyclin-dependent kinases 4 (CDK4) protein level in the breast cancer cells. Knockdown of PAQR4 accelerated degradation of CDK4 together with upregulation of CDK4 polyubiquitination. On the other hand, overexpression of PAQR4 slowed down CDK4 protein degradation and reduced CDK4 polyubiquitination. Collectively, these data at the cellular, animal and human levels indicate that PAQR4 has a tumorigenic effect on human breast cancers, and such effect is associated with a modulatory activity of PAQR4 on protein degradation of CDK4.
Carcinogenesis – Oxford University Press
Published: Mar 8, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.